ENDRA Life Sciences Inc <NDRA.OQ> expected to post a loss of $4.10 a share - Earnings Preview

• ENDRA Life Sciences Inc NDRA.OQ NDRA.O is expected to show no change in quarterly revenue when it reports results on March 26 (estimated) for the period ending December 31 2024

• ​LSEG's mean analyst estimate for ENDRA Life Sciences Inc is for a loss of $4.10 per share.

• The one available analyst rating on the shares is "buy".

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for ENDRA Life Sciences Inc is $75.00​, above​ its last closing price of $4.30. ​​​

This summary was machine generated March 24 at 11:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)